Since the marked positivity for Grp94 in cells of tumor infiltrates, especially B cells, supported the possibility that Grp94 could also be disseminated into the circulation, our next step was to measure Grp94 in patients’ plasma to see whether such measurement could be index of the tumor burden and diffusion, thus representing a useful biomarker. Here, HSP90B1 is linked to neoplasm.